Name and surname:
|
doc. RNDr. Jana Korduláková, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Assistant Professor | Department of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava | 2003 - 2012 |
Associate Professor | Department of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava | 2012 - till now |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Biochemistry (2) | Biochemistry | I. | Chemistry |
Biochemistry | Biology, Medicinal Biology | I. | Biology |
Bachelor Work in Biochemistry (2) | Biochemistry | I. | Chemistry |
Selected Chapters from Biochemistry | Teaching Chemistry | II. | Teaching and Pedagogical Sciences |
Diploma Work in Biochemistry (3) | Biochemistry | II. | Chemistry |
Advanced Biochemistry | Biochemistry | III. | Chemistry |
V.2.a - Name of the study programme | V.2.b - Degree | V.2.c - Field of study |
---|---|---|
Biochemistry | I. | Chemistry |
Biochemistry (conversion programme) | I. | Chemistry |
Biochemistry | II. | Chemistry |
Biochemistry | III. | Chemistry |
V.3.a - Name of the field of habilitation procedure and inaugural procedure | V.3.b - Study field to which it is assigned |
---|---|
Biochemistry (Habilitation procedure) | Chemistry |
V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
---|---|---|---|
Structure and Function of Biomolecules | Biological chemistry | II. | Chemistry |
Perspectives of Chemistry | Chemistry, Biochemistry | I. | Chemistry |
Antibiotics | Biochemistry | II. | Chemistry |
Perspectives of Chemistry | Biochemistry, Biology, Medicinal Biology | I. | chemistry |
ADC - Kordulakova, J., Gilleron, M., Mikusova, K., Puzo, G., Brennan, P. J., Gicquel, B., and Jackson, M. (2002) Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis. PimA is essential for growth of mycobacteria. J Biol Chem 277, 31335-31344, IF (JCR) 2002=6.696
Citations (79)
ADC - Kordulakova, J., Gilleron, M., Puzo, G., Brennan, P. J., Gicquel, B., Mikusova, K., and Jackson, M. (2003) Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of mycobacterium species. J Biol Chem 278, 36285-36295, IF (JCR) 2003=6.482
Citations (50)
ADC - Kordulakova, J., Janin, Y. L., Liav, A., Barilone, N., Dos Vultos, T., Rauzier, J., Brennan, P. J., Gicquel, B., and Jackson, M. (2007) Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother 51, 3824-3829, IF (JCR) 2007=4.989
Citations (18)
ADC - Guerin, M. E., Kordulakova, J., Schaeffer, F., Svetlikova, Z., Buschiazzo, A., Giganti, D., Gicquel, B., Mikusova, K., Jackson, M., and Alzari, P. M. (2007) Molecular recognition and interfacial catalysis by the essential phosphatidylinositol mannosyltransferase PimA from mycobacteria. J Biol Chem 282, 20705-20714, IF (JCR) 2007=5.581
Citations (65)
ADC - Grzegorzewicz, A. E., Pham, H., Gundi, V. A., Scherman, M. S., North, E. J., Hess, T., Jones, V., Gruppo, V., Born, S. E., Kordulakova, J., Chavadi, S. S., Morisseau, C., Lenaerts, A. J., Lee, R. E., McNeil, M. R., and Jackson, M. (2012) Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol 8, 334-341, IF (JCR) 2012=12.948
Citations (155)
ADC - Sabbah, M., Mendes, V., Vistal, R. G., Dias, D. M., Záhorszká, M., Mikušová, K., Korduláková, J., Coyne, A. G., Blundell, T. L., and Abell, C. (2020) Fragment-based design of Mycobacterium tuberculosis InhA inhibitors. Journal of Medicinal Chemistry 63, 4749-4761, IF (JCR) 2019=6,205
ADM - Farjallah, A., Chiarelli, L. R., Forbak, M., Degiacomi, G., Danel, M., Goncalves, F., Carayon, C., Seguin, C., Fumagalli, M., Zahorszka, M., Vega, E., Abid, S., Grzegorzewicz, A., Jackson, M., Peixoto, A., Kordulakova, J., Pasca, M. R., Lherbet, C., and Chassaing, S. (2021) A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis. ACS Infect Dis 7, 552-565, IF (JCR) 2019=4.614
V3 - Chebaiki, M.; Delfourne, E.; Tamhaev, R.; Danoun, S.; Rodriguez, F.; Hoffmann, P.; Grosjean, E.; Goncalves, F.; Azéma-Despeyroux, J.; Pál, A.; Korduláková, J.; Preuilh, N.; Britton, S.; Constant, P.; Marrakchi, H.; Maveyraud, L.; Mourey, L.; Lherbet, C., Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA. European Journal of Medicinal Chemistry 2023, 259, IF (JCR) 2022=6.7
V3 - Karabanovich, G.; Fabianova, V.; Vocat, A.; Dusek, J.; Valaskova, L.; Stolarikova, J.; Kitson, R. R. A.; Pavek, P.; Vavrova, K.; Djaout, K.; Mikusova, K.; Baulard, A. R.; Cole, S. T.; Kordulakova, J.; Roh, J. (2024) Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway. Journal of Medicinal Chemistry 2024, 67 (1), 81-109, IF (JCR) 2022=7.3
V3 - Mistretta, M.; Cimino, M.; Campagne, P.; Volant, S.; Kornobis, E.; Hebert, O.; Rochais, C.; Dallemagne, P.; Lecoutey, C.; Tisnerat, C.; Lepailleur, A.; Ayotte, Y.; LaPlante, S. R.; Gangneux, N.; Zahorszka, M.; Kordulakova, J.; Vichier-Guerre, S.; Bonhomme, F.; Pokorny, L.; Albert, M.; Tinevez, J. Y.; Manina, G. (2024) Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy. Nature Communications, 15 (1), 4175, IF (JCR) 2022=16.6
ADC - Kordulakova, J., Janin, Y. L., Liav, A., Barilone, N., Dos Vultos, T., Rauzier, J., Brennan, P. J., Gicquel, B., and Jackson, M. (2007) Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother 51, 3824-3829:
Cit. 2009 Willand, N. - Dirie, B. - Carette, X. - Bifani, P. - Singhal, A. - Desroses, M. - Leroux, F. - Willery, E. - Mathys, V. - Deprez-Poulain, R. - Delcroix, G. - Frenois, F. - Aumercier, M. - Locht, C. - Villeret, V. - Deprez, B. -Baulard, A.R.: Nature Medicine, Vol. 15, No. 5, 2009, s. 537-544
ADC - Skovierova, H., Larrouy-Maumus, G., Zhang, J., Kaur, D., Barilone, N., Kordulakova, J., Gilleron, M., Guadagnini, S., Belanova, M., Prevost, M. C., Gicquel, B., Puzo, G., Chatterjee, D., Brennan, P. J., Nigou, J., and Jackson, M. (2009) AftD, a novel essential arabinofuranosyltransferase from mycobacteria. Glycobiology 19, 1235-1247:
Cit. 2014 Kieser, K.J.- Rubin, E.J.: Nature Reviews Microbiology, Vol. 12, No. 8, 2014, s. 550-562
ADC - Guerin, M. E., Kordulakova, J., Alzari, P. M., Brennan, P. J., and Jackson, M. (2010) Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria. J Biol Chem 285, 33577-33583:
Cit. 2020 Dulberger, C.L. - Rubin, E.J. - Boutte, C.C.: Nature Reviews Microbiology, Vol. 18, No. 1, 2020, s. 47-59
ADC - Brown, J. R., North, E. J., Hurdle, J. G., Morisseau, C., Scarborough, J. S., Sun, D., Kordulakova, J., Scherman, M. S., Jones, V., Grzegorzewicz, A., Crew, R. M., Jackson, M., McNeil, M. R., and Lee, R. E. (2011) The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg Med Chem 19, 5585-5595:
Cit. 2019 Beddoe, R.H. - Andrews, K.G. - Magne, V. - Cuthbertson, J.D. - Saska, J. - Shannon-Little, A.L. - Shanahan, S.E. - Sneddon, H.F. - Denton, R.M.: Science, Vol. 365, No. 6456, 2019, s. 910
ADC - Grzegorzewicz, A. E., Pham, H., Gundi, V. A., Scherman, M. S., North, E. J., Hess, T., Jones, V., Gruppo, V., Born, S. E., Kordulakova, J., Chavadi, S. S., Morisseau, C., Lenaerts, A. J., Lee, R. E., McNeil, M. R., and Jackson, M. (2012) Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol 8, 334-341:
Cit. 2013 Zumla, A. - Nahid, P. - Cole, S.T.: Nature Reviews Drug Discovery, Vol. 12, No. 5, 2013, s. 388-404
Grant APVV-19-0189: Activation of drugs against tuberculosis (2020 – 2024) - solving 3D structures of selected activating enzymes and characterization of mechanisms of activation/metabolism of ethionamide, rifampicin and pretomanide; principal investigator
Grant VEGA 1/0301/18: Investigation of the mechanism of action of antimycobacterial inhibitors (2018 – 2021) - development of a new methodology for the investigation of mechanisms of action of new antimycobacterial compounds; principal investigator
Grant VEGA 1/0284/15: Activation of thioamide and thiourea antituberculotics in mycobacteria (2015 – 2017) - functional characterization of mycobacterial monooxygenase EthA and investigation of alternative processes of activation of selected antituberculotics; principal investigator
Grant APVV-15-0515: (2016 – 2020) –Topological aspects of biosynthesis of mycobacterial arabinogalactan - functional characterization of selected mycobacterial ABC transporters; co-investigator
Grant MŠ SR, 0395/2016: Design, synthesis and study of the mechanism of action of new original heterocyclic compounds that have activity against latent tuberculosis (2017 – 2019) - revealing the mechanisms of action of potent antimycobacterial inhibitors; co-investigator
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
Member of the Board for the Doctoral Study Program "Biochemistry" | Faculty of Natural Sciences, Comenius University in Bratislava | 2014 - till now |
Member of the state exam committee for Biochemistry master's degree | Faculty of Natural Sciences, Comenius University in Bratislava | 2014 - till now |
Member of the state exam committee for Biochemistry bachelor's degree | Faculty of Natural Sciences, Comenius University in Bratislava | 2014 - till now |
Member of the VEGA Evaluation Committee for Medical and Pharmaceutical Sciences | Ministry of Education of the SR | 2016 - till now |
VIII.a - Name of the institution | VIII.b - Address of the institution | VIII.c - Duration (indicate the duration of stay) | VIII.d - Mobility scheme, employment contract, other (describe) |
---|---|---|---|
Microbiology, Immunology, and Pathology Department, Colorado State University, Fort Collins, USA | Colorado State University, Fort Collins, Colorado 80523 USA | May - July 1999 | Work on the project within the MSc. study, based on the invitation from dr. D. Chatterjee |
Mycobacterial Genetics Unit, Institut Pasteur, Paris, France | 25-28 Rue du Dr Roux, 75015 Paris, France | April - December 2001 | Work on the project within the PhD. study, based on the invitation from prof. Mary Jackson |
Mycobacterial Genetics Unit, Institut Pasteur, Paris, France | 25-28 Rue du Dr Roux, 75015 Paris, France | June - July 2002 | Work on the project within the PhD. study, awarded by French goverment fellowship |
Microbiology, Immunology, and Pathology Department, Colorado State University, Fort Collins, USA | Colorado State University, Fort Collins, Colorado 80523 USA | January - March 2003 | Work on the project within the PhD. study, based on the invitation from dr. M. McNeil |
Mycobacterial Genetics Unit, Institut Pasteur, Paris, France | 25-28 Rue du Dr Roux, 75015 Paris, France | May 2004 - December 2006 | Postdoctoral stay, awarded by Heiser fellowship (The New York Community Trust) |